Blood Glucose Monitoring Device Market Size was valued at USD 12.54 billion in 2022 and is projected to reach USD 23.05 billion by 2030, with a compound annual growth rate (CAGR) of 7.9% during the forecast period from 2023 to 2030.
This significant growth in the Blood Glucose Monitoring Device market can be attributed to various factors. The rising prevalence of diabetes worldwide, coupled with the increasing awareness about the importance of regular glucose monitoring, has led to a surge in demand for these devices. Additionally, advancements in technology have resulted in the development of more accurate and user-friendly glucose monitoring devices, further driving market growth.
Furthermore, the growing geriatric population, which is more susceptible to diabetes, is expected to contribute to the market expansion. Moreover, the adoption of sedentary lifestyles and unhealthy dietary habits in both developed and developing countries has led to a higher incidence of diabetes, thereby fueling the demand for glucose monitoring devices.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/1013
In terms of regional analysis, North America currently dominates the Glucose Monitoring Device market, owing to the high prevalence of diabetes and the presence of well-established healthcare infrastructure. However, the Asia Pacific region is anticipated to witness the fastest growth during the forecast period, primarily due to the increasing diabetic population and improving healthcare facilities in countries like China and India.
Key market players in the Blood Glucose Monitoring Device industry are continuously focusing on research and development activities to introduce innovative products and gain a competitive edge. Moreover, strategic collaborations, mergers, and acquisitions are also prevalent strategies adopted by these companies to expand their market presence.
In conclusion, the Blood Glucose Monitoring Device market is poised for substantial growth in the coming years, driven by factors such as the rising prevalence of diabetes, technological advancements, and increasing awareness about the importance of glucose monitoring. With the Asia Pacific region expected to witness significant growth, market players are actively engaged in research and development efforts to introduce cutting-edge products and gain a competitive advantage in this expanding.
KEY MARKET SEGMENTATION:
By Product
Self-monitoring Devices:
- Blood Glucose Meter
- Testing Strips
- Lancets
Continuous Blood Glucose Monitoring Devices
- Sensors
- Transmitter & Receiver
- Insulin Pumps
By End-use
- Hospitals
- Home Care
- Diagnostic Centers
Major Players Listed in the Report are as Follows:
Medtronic plc, Sanofi, Ascensia Diabetes Care, Dexcom, Inc., Abbott Laboratories, Insulet Corporation, Ypsomed Holdings, Novo Nordisk, Glysens Incorporated, F. Hoffmann-La Roche Ltd and Others.
Other Reports You May Like:
Veterinary Digital Pathology market
Molecular Diagnostics Market
Medical Second Opinion Market
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),
Website: https://www.snsinsider.com